Featured Research

from universities, journals, and other organizations

Boosting The BCG Vaccine To Beat Tuberculosis

Date:
August 20, 2005
Source:
Journal of Clinical Investigation
Summary:
In a new JCI study scientists describe a novel vaccine strain with high efficacy against tuberculosis. The new BCG vaccine strain protects mice against tuberculosis significantly better than the parental BCG. Superior protection is not only induced against the laboratory strain of M. tuberculosis but also against a clinical isolate of the Beijing/W family, a straing of tuberculosis that is spreading all over the world, is drug-resistant, and is responsible for the most threatening disease outbreaks.

Tuberculosis remains a major global health threat. Although morethan 3 billion doses of the BCG vaccine have been administered to fighttuberculosis, the ability of the BCG vaccine to protect adults is verylimited, as is its efficacy against newly emerging isolates.

Related Articles


In a study appearing online on August 18 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation,Stefan Kaufmann and colleagues from the Max Planck Institute devise astrategy to boost the immunogenicity of BCG and describe a novelvaccine strain with high efficacy against tuberculosis. The researchersengineer a BCG strain that secretes the listeriolysin protein, whichpunches holes in the membranes of phagosomes where M. tuberculosis islocated, allowing better T cell-mediated immunity. Becauselisteriolysin works optimally at a pH of 5.8, the researchers alsodeleted the urease C gene of BCG, which normally plays a role in pHneutralization of the phagosome. The lack of urease C allows phagosomalacidification and provides an ideal pH environment for listeriolysin.

The new BCG vaccine strain protects mice against tuberculosissignificantly better than the parental BCG. Superior protection is notonly induced against the laboratory strain of M. tuberculosis but alsoagainst a clinical isolate of the Beijing/W family, a straing oftuberculosis that is spreading all over the world, is drug-resistant,and is responsible for the most threatening disease outbreaks.

###

TITLE: Increased vaccine efficacy against tuberculosis ofrecombinant Mycobacterium bovis bacille Calmette-Guιrin mutants thatsecrete listeriolysin

View the PDF of this article at: https://www.the-jci.org/article.php?id=24617


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Boosting The BCG Vaccine To Beat Tuberculosis." ScienceDaily. ScienceDaily, 20 August 2005. <www.sciencedaily.com/releases/2005/08/050819133159.htm>.
Journal of Clinical Investigation. (2005, August 20). Boosting The BCG Vaccine To Beat Tuberculosis. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2005/08/050819133159.htm
Journal of Clinical Investigation. "Boosting The BCG Vaccine To Beat Tuberculosis." ScienceDaily. www.sciencedaily.com/releases/2005/08/050819133159.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins